Nuvoton Releases 4th Generation of "Gerda (TM)," Automotive HMI Display IC Series, in 3 Variants
This new lineup features image-processing technology, security, and display safety functions to support the higher level of safety requirement and more comfortable driving experiences. The Gerda (TM) IC contributes to the development of next-generation HMI systems by enabling high-performance, cost-effective solutions across a wide range of applications.
Image: https://cdn.kyodonewsprwire.jp/prwfile/release/M108245/202505209125/_prw_PI1fl_zY63S04Z.jpg
1. Superior image-processing engine for improving visibility and comfort of HMI equipment
For Electronic Mirrors
Gerda-4M solves the issues that conventional e-mirrors have, such as glare caused by strong lights and reduced visibility due to loss of detail in high-contrast lighting scenarios, especially at night, by using a "local contrast function" that locally adjusts the screen contrast based on the luminance distribution of each area. In addition, low-latency processing of less than one frame enables real-time display improvements.
Figure1: https://cdn.kyodonewsprwire.jp/prwfile/release/M108245/202505209125/_prw_PI2fl_2Cch7lSf.jpg
For AR-HUDs
AR-HUD displays must align precisely with windshield curvature and driver's line of sight. The image-warping engine in Gerda (TM) enables free image deformation with low latency of less than one frame, allowing it to fit the windshield. It also supports "dual projection," which projects images both near and far focus with a single chip.
Figure2: https://cdn.kyodonewsprwire.jp/prwfile/release/M108245/202505209125/_prw_PI3fl_m566UT8D.jpg
For Cluster Meters
With a 2.5D graphics engine (GFX), Gerda (TM) enables user interface (UI) design that simulates 3D effects using 2D elements. This improves depth perception and readability, contributing to more accurate and timely decision-making by the driver. Additionally, in combination with an image compression engine, it supports high-resolution output of WXGA@60FPS, providing a modern, high-quality dashboard experience.
2. Generally, high-performance HMI solutions require external memory. NTCJ's Gerda (TM) Gen-4 series is embedded with high speed and large capacity memory which eliminates external memory, helping to reduce the number of components and system costs. In addition, Gerda-4L is equipped with a dedicated image compression engine, achieving real-time processing while using only half the memory -- making it possible to display high-resolution images at WXGA@60FPS only using embedded memory.
Figure3: https://cdn.kyodonewsprwire.jp/prwfile/release/M108245/202505209125/_prw_PI4fl_h4akP54x.jpg
3. The Gen-4 Gerda (TM) lineup includes display safety functions such as video signal monitoring and alert display monitoring, and contributes to realizing system designs that meet ISO26262 ASIL-B requirements by supporting fail-safe and real-time monitoring.
Additionally, the integrated Hardware Security Module (HSM), compliant with EVITA-Full, enables secure OTA software updates and a secure boot which allows only trusted software boots -- protecting against vehicle cybersecurity threats.
NTCJ is the first Japanese company which has been certified with the TUV process of ISO/SAE21434 and continues to improve cybersecurity at supply chains and its reliability.
For more details about the product, visit: https://nuvoton.co.jp/semi-spt/apl/rd/?id=1100-0068
About Nuvoton Technology Corporation Japan: https://www.nuvoton.co.jp/en/
View original content:https://www.prnewswire.com/apac/news-releases/nuvoton-releases-4th-generation-of-gerda-tm-automotive-hmi-display-ic-series-in-3-variants-302475069.html
SOURCE Nuvoton Technology Corporation Japan
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Proteomics Market to Expand Rapidly, with 13% CAGR forecast Through 2030
"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON, July 25, 2025 /PRNewswire/ -- According to the latest study from BCC Research, "Proteomics: Technologies and Global Markets" was valued at $27.6 billion in 2024 and is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030. The report offers a detailed analysis of the global market for proteomic technologies, segmented by product type (instruments and software, consumables), platform (mass spectrometry, biochip), application (drug discovery and development, research, diagnostics, applied proteomics), and region (North America, Europe, Asia-Pacific, and Rest of the World). Protein structural analysis and protein-expression products are outside the scope of the report. The study discusses market trends, challenges, and emerging technologies, while also examining the competitive landscape and the market shares of leading vendors. It includes a section on ESG trends and provides company profiles that include insights into financials, product portfolios, and recent advances. This analysis serves as a valuable resource for understanding strategic opportunities and market dynamics in the evolving proteomics sector. This report is particularly relevant today due to the growing demand for innovative and personalized therapies, which is driving advances in proteomic technologies. Increased investments in R&D are accelerating the discovery of new biomarkers, which are crucial for early and accurate diagnosis of diseases. These trends underscore the importance of proteomics in shaping the future of precision medicine and improving healthcare outcomes. The factors driving the market's growth include: Increasing Investments in R&D: Governments, biotech firms, and academic institutions are increasing funding in proteomics research to drive innovation in diagnostics, drug discovery, and therapeutic development. Transition Towards Personalized Medicine: Proteomics enables the identification of protein biomarkers that support tailored treatments based on individual biological profiles, making it a cornerstone in the shift toward personalized healthcare. Aging Population and Prevalence of Chronic Diseases: As the global population ages, chronic conditions like cancer and cardiovascular diseases are becoming more common, increasing the demand for proteomics tools that aid in early detection and targeted treatment. Emerging Technologies: Advances such as high-resolution mass spectrometry, AI-driven data analysis, and single-cell proteomics are accelerating research making it more precise, and cost-effective, thereby expanding the scope and impact of proteomics. Request a sample copy of the global market for proteomic technologies report. Report Synopsis Report Metric Details Base year considered 2024 Forecast period considered 2025-2030 Base year market size $27.6 billion Market size forecast $57.2 billion Growth rate CAGR of 13.0% from 2025 to 2030 Segments covered Platform, Application, Product Type and Region Regions covered North America, Europe, Asia-Pacific and the Rest of the World (RoW) Countries covered U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, Japan, China, India, South Korea, Rest of Asia-Pacific, and Rest of Europe Market drivers Increasing investments in R&D. Transition towards personalized medicine. Aging population and growing prevalence of chronic diseases. Emerging technologies. Interesting facts: Advances in Technology: The market has seen notable progress in mass spectrometry, particularly with improvements in software and automation that streamline essential processes like sample preparation. Innovation from Emerging Companies: Start-up companies such as Nautilus and SomaLogic have introduced innovative platforms that are expected to reshape the market's future. Emerging startup: Alamar Biosciences Nautilus Biotechnology Pixelgen Technologies Syncell Inc. Sengenics The report addresses the following questions: What is the projected size and growth rate of the market?- The global proteomics market was valued at $27.6 billion in 2024 and is expected to grow at a CAGR of 13% to reach $57.2 billion by the end of 2030. Which factors are driving the growth of the market?- The global market of proteomic technologies is growing due to the rising aging population and growing prevalence of chronic diseases, increasing investments in R&D and in the biotechnology sector, and rising demand for personalized medicine. Which market segments are covered in the report?- The global market for proteomic technologies is segmented based on platform, product type, application, and region. Which platform type will be dominant through 2030?- The mass spectrometry segment will be dominant through 2030. Which region has the largest market share?- North America holds the largest share of the market. Market Leaders include: AGILENT TECHNOLOGIES INC. ARRAYIT CORP. BIO-RAD LABORATORIES INC. BIO-TECHNE BRUKER CREATIVE PROTEOMICS DANAHER CORP. JEOL LTD. MERCK KGAA PROMEGA CORP. REVVITY SHIMADZU CORP. STANDARD BIOTOOLS THERMO FISHER SCIENTIFIC INC. WATERS CORP. Related reports: Single-Cell Genomics and Proteomics: Emerging Technologies and Markets: This report reviews the single-cell genomics and proteomics market, highlighting its current landscape and future potential. It examines key market drivers, challenges, and opportunities, and segments the market by product type (genomics, epigenomics, transcriptomics), application areas (oncology and immunology), end users (academic institutions and biotech companies), and regions (North America, Europe, Asia-Pacific, and the Rest of the World). It also includes profiles of major companies, covering their business segments, financials, product offerings, and recent developments. Global Multiomics Market: This report provides a detailed analysis of the global multiomics market, focusing on products, platforms, applications, end-users, and regions. It explores market trends and forecasts, along with insights into major players and geographic opportunities. The report also includes strategic tools like PESTEL and ESG analysis, competitive assessments, and recommendations to help companies plan effectively. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC
Yahoo
2 hours ago
- Yahoo
InventHelp Inventors Develop New Emergency Vehicle Alert Feature (LOS-323)
PITTSBURGH, July 25, 2025 /PRNewswire/ -- "We wanted to create a vehicle system to warn drivers of an approaching emergency vehicle," said one of two inventors, from Burbank, Calif., "so we invented the SAFE SIREN. Our design prevents the emergency vehicle from being overlooked, and it could help prevent serious collisions." The invention provides an effective way to alert motorists to the presence of approaching emergency vehicles. In doing so, it allows more time for the driver to react and yield right-of-way. As a result, it increases safety, and it helps prevent confusion or sudden surprises. The invention features an automatic design that is easy to use so it is ideal for vehicle owners. Additionally, a prototype model and technical drawings are available upon request. The original design was submitted to the Los Angeles sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-LOS-323, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp
Yahoo
5 hours ago
- Yahoo
TriNet Announces Second Quarter 2025 Results & Reaffirms Full Year 2025 Guidance
DUBLIN, Calif., July 25, 2025 /PRNewswire/ -- TriNet Group, Inc. (NYSE: TNET), a leading provider of comprehensive and flexible human capital management (HCM) solutions for small and medium-size businesses (SMBs), today announced financial results for the second quarter ended June 30, 2025. The second quarter highlights below include non-GAAP financial measures which are reconciled later in this release. "Our second quarter financial performance was in-line with our forecast and keeps us on track to achieve our full-year guidance," said Mike Simonds, TriNet President and CEO. "We continued to execute our strategy while supporting our SMB customers through the volatile business environment." Simonds continued, "During the quarter, we prudently repriced our benefits offering, while maintaining customer retention above our historical average. With several growth initiatives on track for the fall, we are excited to drive new sales with an expanded go-to-market approach coupled with improvements to our offering." Second quarter highlights include: Total revenues were $1.2 billion, flat compared to the same period last year. Professional service revenues decreased 8% to $172 million compared to the same period last year. Net income was $37 million, or $0.77 per diluted share, compared to net income of $60 million, or $1.20 per diluted share, in the same period last year. Adjusted Net Income was $55 million, or $1.15 per diluted share, compared to Adjusted Net Income of $78 million, or $1.53 per diluted share, in the same period last year. Adjusted EBITDA was $105 million, representing an Adjusted EBITDA Margin of 8.5%, compared to Adjusted EBITDA of $136 million, representing an Adjusted EBITDA Margin of 10.9%, in the same period last year. Average WSEs decreased 4% compared to the same period last year, to approximately 336,000. Returned $117 million to shareholders through share repurchases and dividends during the first half of 2025. Full-Year 2025 Guidance In addition to announcing our second quarter 2025 results, we are reiterating our full-year 2025 guidance. Non-GAAP financial measures are reconciled later in this Year 2025 (dollars in millions, except for per share amounts) LowHigh Total Revenues $4,950$5,140 Professional Service Revenues $700$730 Insurance Cost Ratio 92 %90 % Adjusted EBITDA Margin 7 %9 % Diluted net income per share of common stock $1.90$3.40 Adjusted Net Income per share - diluted $3.25$4.75 Quarterly Report on Form 10-Q We anticipate filing our Quarterly Report on Form 10-Q ("Form 10-Q") for the first half of 2025 with the U.S. Securities and Exchange Commission (SEC) and making it available at today, July 25, 2025. This press release should be read in conjunction with the Form 10-Q and the related Notes to Consolidated Financial Statements and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the Form 10-Q. Earnings Conference Call and Audio Webcast TriNet will host a conference call at 5:30 a.m. PT (8:30 a.m. ET) today to discuss its second quarter results for 2025 and reaffirm its full-year financial guidance for 2025. TriNet encourages participants to pre-register for the webcast and conference call. The live webcast of the conference call can be accessed on the Investor Relations section of TriNet's website at Participants can pre-register for the webcast by going to: Callers can pre-register by going to: For those who would like to join the call but have not pre-registered, they can do so by dialing +1 (412) 317-5426 and requesting the "TriNet Conference Call." A replay of the webcast will be available on this website for approximately one year. A telephonic replay will be available for two weeks following the conference call at +1 (412) 317-0088 conference ID: 7260452. About TriNet TriNet is a leading provider of Human Resources solutions for small and medium size businesses, offering advanced technology-enabled services that include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. Our long-term objective is to be the premier provider of HR services for a broad range of SMBs through industry leading benefits, sales distribution excellence, and a world class services delivery model. For more information, visit or follow us on Facebook, LinkedIn and Instagram. Use of Non-GAAP Financial Measures Reconciliations of non-GAAP financial measures to TriNet's financial results as determined in accordance with GAAP are included at the end of this press release following the accompanying financial data. For a description of these non-GAAP financial measures, including the reasons management uses each measure, please see the section titled "Non-GAAP Financial Measures." Forward-Looking Statements This press release contains, and statements made during the above referenced conference call will contain, statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21 of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, including, among other things, TriNet's expectations and assumptions regarding: TriNet's financial guidance for the full-year 2025 and the underlying assumptions; TriNet's ability to achieve improvements in its results in 2026; the timing of TriNet's growth initiatives, TriNet's ability to drive new sales and maintain disciplined pricing and TriNet's ability to further benefit its customers with its product investments and service delivery model. Forward-looking statements are often identified by the use of words such as, but not limited to, "ability," "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "guidance," "impact," "intend," "may," "plan," "predict," "project," "seek," "should," "strategy," "target," "value," "will," "would" and similar expressions or variations. These statements are not guarantees of future performance but are based on management's expectations as of the date hereof and assumptions that are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from our current expectations and any past or future results, performance or achievements. Investors are cautioned not to place undue reliance upon any forward-looking statements. Important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements include: our ability to manage unexpected changes in workers' compensation and health insurance claims and costs by WSEs; our ability to mitigate the unique business risks we face as a co-employer; the effects of volatility in the financial and economic environment on the businesses that make up our client base; our inability to realize or sustain the expected benefits from our business realignment initiatives; loss of clients for reasons beyond our control and the short-term contracts we typically use with our clients; the impact of regional or industry-specific economic and health factors on our operations; the impact of failures or limitations in the business systems and centers we rely upon; the impact of discontinuing our discretionary credits on our business and client loyalty and retention; changes in our insurance coverage or our relationships with key insurance carriers; our ability to improve our services and technology to satisfy client and regulatory expectations; our ability to effectively integrate businesses we have acquired or may acquire in the future; our ability to effectively manage and improve our operational effectiveness and resiliency; our ability to attract and retain qualified personnel; the effects of increased competition and our ability to compete effectively; the impact on our business of cyber-attacks, breaches, disclosures and other data-related incidents; our ability to comply with evolving data privacy, AI and security laws; our ability to manage changes in, uncertainty regarding, or adverse application of the complex laws and regulations that govern our business; changing laws and regulations governing health insurance and employee benefits; our ability to keep pace with changes in technology or provide timely enhancements to our solutions and support; risks associated with our international operations; our ability to operate a business subject to numerous complex laws; changing laws and regulations governing health insurance and other traditional employee benefits at the federal, state, and local levels; our ability to be recognized as an employer of worksite employees and for our benefits plans to satisfy all requirements under federal and state regulations; changes in the laws and regulations that govern what it means to be an employer, employee or independent contractor; the impact of new and changing laws regarding remote work; our ability to comply with the licensing requirements that govern our solutions; the failure of third-party service providers performing their functions; the failure to comply with anti-corruption laws and regulations, economic and trade sanctions, and similar laws; the outcome of existing and future legal and tax proceedings; fluctuation in our results of operations and stock price due to factors outside of our control; our ability to comply with the restrictions of our indebtedness and meet our debt obligations; the need for additional capital or to restructure our existing debt; the continuation of our stock repurchase program; the impact of concentrated ownership in our stock by Atairos and other large stockholders; and the anti-takeover provisions in our charter documents and under Delaware law. Any of these factors could cause our actual results to differ materially from our anticipated results. Further information on risks that could affect TriNet's results is included in our filings with the SEC, including under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are available on our investor relations website at and on the SEC website at Copies of these filings are also available by contacting TriNet Corporation's Investor Relations Department at (510) 875-7201. Except as required by law, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements in this press release, and any forward-looking statements in this press release speak only as of the date of this press release. In addition, we do not assume any obligation, and do not intend, to update any of our forward-looking statements, except as required by law. Contacts:Investors: Media: Alex Bauer Renee Brotherton TriNet TriNet (510) 875-7201 (925) 965-8441 Key Financial and Operating Metrics We regularly review certain key financial and operating metrics to evaluate growth trends, measure our performance and make strategic decisions. These key financial and operating metrics may change over time. Our key financial and operating metrics for the periods presented were as follows:Three Months Ended June 30,Six Months Ended June 30, (in millions, except per share and Operating Metrics data) 20252024% Change20252024%Change Income Statement Data:Total revenues $ 1,238$ 1,243— %$ 2,530$ 2,525— % Income before tax 5181(37) 166205(19)Net income 3760(38) 122152(20)Diluted net income per share of common stock 0.771.20(36) 2.482.98(17)Non-GAAP measures (1):Adjusted EBITDA 105136(23) 268316(15)Adjusted Net income 5578(29) 154189(19)Free Cash Flow1379544Operating Metrics:Insurance Cost Ratio 90 %88 %2 %89 %87 %2Average WSEs 336,010351,455(4) 338,377349,810(3) % Total WSEs 338,900354,028(4) 338,900354,028(4)(1) Refer to Non-GAAP measures definitions and reconciliations from GAAP measures under the heading "Non-GAAP Financial Measures" (in millions) June 30, 2025December 31, 2024% ChangeBalance Sheet Data: Cash and cash equivalents $ 407$ 36013 % Working capital 25419928Total assets 3,6884,119(10)Debt 984983—Total stockholders' equity 1076955 Six Months Ended June 30, (in millions) 20252024% Change Cash Flow Data: Net cash provided by operating activities $ 170$ 13031 % Net cash used in investing activities (7)(47)(85)Net cash used in financing activities (428)(555)(23) TRINET GROUP, STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited) Three Months Ended June 30,Six Months Ended June 30, (in millions except per share data) 2025 20242025 2024 Professional service revenues $ 172 $ 186$ 381 $ 400 Insurance service revenues 1,048 1,0402,113 2,090 Interest income 18 1736 35 Total revenues 1,238 1,2432,530 2,525 Insurance costs 947 9161,889 1,823 Cost of providing services 71 75142 154 Sales and marketing 68 72135 144 General and administrative 52 4798 95 Systems development and programming 17 1737 35 Depreciation and amortization of intangible assets 17 1934 37 Interest expense, bank fees and other 15 1629 32 Total costs and operating expenses 1,187 1,1622,364 2,320 Income before tax 51 81166 205 Income taxes 14 2144 53 Net income $ 37 $ 60$ 122 $ 152 Other comprehensive income (loss), net of income taxes 1 —3 (3) Comprehensive income $ 38 $ 60$ 125 $ 149 Net income per share:Basic $ 0.77 $ 1.21$ 2.49 $ 3.01 Diluted $ 0.77 $ 1.20$ 2.48 $ 2.98 Weighted average shares:Basic 48 5049 50 Diluted 49 5149 51 TRINET GROUP, BALANCE SHEETS (Unaudited) June 30,December 31, (in millions, except share and per share data)20252024 Assets Current assets: Cash and cash equivalents$ 407$ 360 Restricted cash, cash equivalents and investments1,1011,413 Accounts receivable, net1232 Payroll funds receivable487349 Prepaid expenses, net5064 Other payroll assets660916 Other current assets4546 Total current assets2,7623,180 Restricted cash, cash equivalents and investments, noncurrent124145 Property and equipment, net1010 Operating lease right-of-use asset3924 Goodwill461461 Software and other intangible assets, net148156 Other assets144143 Total assets$ 3,688$ 4,119 Liabilities and stockholders' equity Current liabilities: Accounts payable and other current liabilities$ 85$ 89 Revolving credit agreement borrowings9075 Client deposits and other client liabilities4176 Accrued wages562580 Accrued health insurance costs, net191189 Accrued workers' compensation costs, net4644 Payroll tax liabilities and other payroll withholdings1,4841,906 Operating lease liabilities313 Insurance premiums and other payables69 Total current liabilities2,5082,981 Long-term debt, noncurrent894908 Accrued workers' compensation costs, noncurrent, net109110 Deferred taxes1011 Operating lease liabilities, noncurrent4826 Other non-current liabilities1214 Total liabilities3,5814,050 Total stockholders' equity10769 Total liabilities & stockholders' equity$ 3,688$ 4,119 TRINET GROUP, STATEMENTS OF CASH FLOWS (Unaudited)Six Months Ended June 30, (in millions) 2025 2024 Operating activities Net income $ 122 $ 152 Adjustments to reconcile net income to net cash used in operating activities: Depreciation and amortization of intangible assets 33 37 Amortization of deferred costs 23 21 Amortization of ROU asset, lease modification, impairment, and abandonment 3 3 Deferred income taxes (1) — Stock based compensation 31 38 Loss from disposition of assets 1 — Other 3 1 Changes in operating assets and liabilities: Accounts receivable, net 1 (4) Prepaid expenses, net 9 (18) Other assets (18) (35) Other payroll assets — 2 Accounts payable and other liabilities (5) (8) Client deposits and other client liabilities (1) (9) Accrued wages (10) (20) Accrued health insurance costs, net 1 (1) Accrued workers' compensation costs, net (1) (14) Payroll taxes liabilities and other payroll withholdings (14) (8) Operating lease liabilities (7) (7) Net cash provided by operating activities 170 130 Investing activities Purchases of marketable securities (41) (137) Proceeds from sale and maturity of marketable securities 66 125 Acquisitions of property and equipment and software (33) (35) Sale of property and equipment and software — — Proceeds from sale of business 1 — Net cash used in investing activities (7) (47) Financing activities Change in WSE and TriNet Trust related assets and liabilities, net (310) (382) Repurchase of common stock (91) (135) Proceeds from issuance of common stock 7 7 Awards effectively repurchased for required employee withholding taxes (8) (12) Repayment of revolving credit agreement borrowings — (25) Dividends paid (26) (13) Net cash used in financing activities (428) (560) Net change in cash and cash equivalents, unrestricted and restricted (265) (477) Cash and cash equivalents, unrestricted and restricted: Beginning of period 1,691 1,466 End of period $ 1,426 $ 989Supplemental disclosures of cash flow information Interest paid $ 27 $ 30 Income taxes paid, net $ 26 $ 62 Supplemental schedule of noncash investing and financing activities Cash dividend declared, but not yet paid $ 13 $ 12 Payable for purchase of property and equipment $ 3 $ 2 Receivable from sale of business $ 6 $ — Non-GAAP Financial Measures In addition to the selected financial measures presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP), we monitor other non-GAAP financial measures that we use to manage our business, to make planning decisions, to allocate resources and to use as performance measures in our executive compensation plan. These key financial measures provide an additional view of our operational performance over the long term and provide information that we use to maintain and grow our business. The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation from, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. Non-GAAP Measure Definition How We Use The Measure Adjusted EBITDA • Net income, excluding the effects of: - income tax provision, - interest expense, bank fees and other, - depreciation, - amortization of intangible assets, - stock based compensation expense, - amortization of cloud computing arrangements, and - restructuring costs • Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates theeffectiveness of our business strategies by excluding certain non-recurring costs, which include restructuring costs, as well as certainnon-cash charges such as depreciation and amortization, and stock-based compensationand certain impairment charges recognizedbased on the estimated fair values. We believe these charges are either not directly resulting from our core operations or not indicative of our ongoing operations • Enhances comparisons to the prior periodand, accordingly, facilitates the developmentof future projections and earnings growthprospects • Provides a measure, among others, used inthe determination of incentive compensationfor management • We also sometimes refer to Adjusted EBITDA margin, which is the ratio of Adjusted EBITDA to total revenues Adjusted Net Income • Net income, excluding the effects of: - effective income tax rate (1), - stock based compensation expense, - amortization of intangible assets, net, - non-cash interest expense, - restructuring costs, and - the income tax effect (at our effective taxrate (1) of these pre-tax adjustments.) • Provides information to our stockholdersand board of directors to understand how ourmanagement evaluates our business, to monitor and evaluate our operating results,and analyze profitability of our ongoingoperations and trends on a consistent basis by excluding certain non-cash charges Free Cash Flow • Net cash provided by operating activitiesreduced by capital expenditures • Provides information on the strength of our liquidity and available cash • Provides management with a measure to assist in making planning decisions, evaluateour performance and allocate resources • We also sometimes refer to Free Cash FlowConversion ratio, which is the ratio of free cash flow to Adjusted EBITDA (1) Non-GAAP effective tax rate is 25.0% and 25.6% for the second quarters and full years of 2025 and 2024, which excludes the income tax impactfrom stock-based compensation, changes in uncertain tax positions, and nonrecurring benefits or expenses from federal legislative changes. Reconciliation of GAAP to Non-GAAP Measures The table below presents a reconciliation of Net (loss) income to Adjusted EBITDA:Three Months EndedJune 30,Six Months EndedJune 30, (in millions) 2025 20242025 2024 Net income $ 37 $ 60$ 122 $ 152 Provision for income taxes 14 2144 53 Stock based compensation 18 1831 38 Interest expense, bank fees and other 15 1629 32 Depreciation and amortization of intangible assets 17 1934 37 Amortization of cloud computing arrangements 2 25 4 Restructuring costs 2 —3 — Adjusted EBITDA $ 105 $ 136$ 268 $ 316 Adjusted EBITDA Margin 8.5 % 10.9 %10.6 % 12.5 % The table below presents a reconciliation of Net (loss) income to Adjusted Net Income and Adjusted Net Income per share - diluted:Three Months Ended June 30,Six Months Ended June 30, (in millions, except per share data) 2025 20242025 2024 Net income $ 37 $ 60$ 122 $ 152 Effective income tax rate adjustment 1 —2 1 Stock based compensation 18 1831 38 Amortization of intangible assets 3 55 10 Non-cash interest expense — 11 1 Restructuring costs 2 —3 — Income tax impact of pre-tax adjustments (6) (6)(10) (13) Adjusted Net Income $ 55 $ 78$ 154 $ 189 GAAP weighted average shares of common stock - diluted 49 5149 51 Adjusted Net Income per share - diluted $ 1.15 $ 1.53$ 3.15 $ 3.70 The table below presents a reconciliation of Net cash provided by operating activities to Free Cash Flow:Six Months Ended June 30, (in millions) 2025 2024 Net cash provided by operating activities $ 170 $ 130 Acquisitions of property and equipment and projects in process (33) (35) Free Cash Flow (a) $ 137 $ 95 Adjusted EBITDA (b) $ 268 $ 316 Free Cash Flow Conversion Ratio (a)/(b) 51 % 30 % Reconciliation of GAAP to Non-GAAP Measures for the full-year 2025 guidance. Low and high percentages represent increases (decreases) from the same period in the previous year. The table below presents a reconciliation of net income to Adjusted Net Income and Adjusted Net Income per share - diluted:FY 2024Year 2025 Guidance (in millions, except per share data) ActualLow High Net income $173(46) % (3) % Effective income tax rate adjustment (5)(83) (105) Stock based compensation 6511 11 Amortization of intangible assets 19(49) (49) Non-cash interest expense 3(100) (100) Restructuring costs 49(80) (80) Income tax impact of pre-tax adjustments (35)(32) (32) Adjusted Net Income $269(40) % (12) % GAAP weighted average shares of common stock - diluted 50Adjusted Net Income per share - diluted $5.32$3.25 $4.75 View original content to download multimedia: SOURCE TriNet Group, Inc.
